Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Füssel

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
European Urology|May 27, 2008
Editorial comment on: Molecular cancer phenotype in normal prostate tissueSusanne Füssel
OTO Open|February 13, 2026
Relationship Between Nasal Trigeminal Receptor Expression and Trigeminal SensitivityAkshita Joshi, Yiling Mai, Susanne Füssel, et al.
Biochemistry|September 25, 2002
Substrate-based design of reversible Pin1 inhibitorsYixin Zhang, Susanne Füssel, Ulf Reimer, et al.
Der Urologe. Ausg. A|May 1, 2016
[Annual meeting of the German Prostate Cancer Consortium: Updates to circulating tumor cells, "liquid biopsy" and the role of the androgen receptor]Helge Taubert, Christoph Becker, Susanne Füssel, et al.
Journal of Cancer Research and Clinical Oncology|January 8, 2026
Type I-interferon β induces a strong anti-tumour response in bladder cancer cellsMarlena Hesse, Max Iltzsche, Daniel Nahhas, et al.
Urologie (Heidelberg, Germany)|February 24, 2026
[Report from the 16th annual meeting of the DFBK, 16-17th January 2026 in Ulm]Thorsten H Ecke, Roman Nawroth, Susanne Füssel, et al.
Cancers|November 12, 2013
Tumor-associated antigens for specific immunotherapy of prostate cancerAndrea Kiessling, Rebekka Wehner, Susanne Füssel, et al.
Cancer Letters|April 15, 2003
Tissue specific expression and serum levels of human tissue factor in patients with urological cancerYvonne Förster, Axel Meye, Sybille Albrecht, et al.
Journal of Nanobiotechnology|July 19, 2017
Systematic evaluation of oligodeoxynucleotide binding and hybridization to modified multi-walled carbon nanotubesAnika Kaufmann, Silke Hampel, Christiane Rieger, et al.
Cancers|January 11, 2022
Systemic Triple Therapy in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Ready for Prime Time or Still to Be Explored?Christian Thomas, Martin Baunacke, Holger H H Erb, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
European Urology|May 27, 2008
Editorial comment on: Molecular cancer phenotype in normal prostate tissueSusanne Füssel
OTO Open|February 13, 2026
Relationship Between Nasal Trigeminal Receptor Expression and Trigeminal SensitivityAkshita Joshi, Yiling Mai, Susanne Füssel, et al.
Biochemistry|September 25, 2002
Substrate-based design of reversible Pin1 inhibitorsYixin Zhang, Susanne Füssel, Ulf Reimer, et al.
Der Urologe. Ausg. A|May 1, 2016
[Annual meeting of the German Prostate Cancer Consortium: Updates to circulating tumor cells, "liquid biopsy" and the role of the androgen receptor]Helge Taubert, Christoph Becker, Susanne Füssel, et al.
Journal of Cancer Research and Clinical Oncology|January 8, 2026
Type I-interferon β induces a strong anti-tumour response in bladder cancer cellsMarlena Hesse, Max Iltzsche, Daniel Nahhas, et al.
Urologie (Heidelberg, Germany)|February 24, 2026
[Report from the 16th annual meeting of the DFBK, 16-17th January 2026 in Ulm]Thorsten H Ecke, Roman Nawroth, Susanne Füssel, et al.
Cancers|November 12, 2013
Tumor-associated antigens for specific immunotherapy of prostate cancerAndrea Kiessling, Rebekka Wehner, Susanne Füssel, et al.
Cancer Letters|April 15, 2003
Tissue specific expression and serum levels of human tissue factor in patients with urological cancerYvonne Förster, Axel Meye, Sybille Albrecht, et al.
Journal of Nanobiotechnology|July 19, 2017
Systematic evaluation of oligodeoxynucleotide binding and hybridization to modified multi-walled carbon nanotubesAnika Kaufmann, Silke Hampel, Christiane Rieger, et al.
Cancers|January 11, 2022
Systemic Triple Therapy in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Ready for Prime Time or Still to Be Explored?Christian Thomas, Martin Baunacke, Holger H H Erb, et al.
Pageof 5